Brigit Biofarmaka Teknologi Tbk. vs Sawit Sumbermas Sarana Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Sawit Sumbermas Sarana Tbk trades at Rp1,195 (market cap 11.38T, 9.52M 24h volume). The key difference: Sawit Sumbermas Sarana Tbk is far larger — about 68.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sawit Sumbermas Sarana Tbk is more actively traded (9.52M versus 324K). Which is the better fit depends on your goals.
| OBAT | SSMS | |
|---|---|---|
Market Cap | 166.01B | 11.38T |
Volume | 324K | 9.52M |
Lot | 3.24K | 95.2K |
Turnover | 77.68M | 11.42B |
Average Price | 239.75 | 1,199.09 |
Value | 77.68M | 11.42B |
Indicative Equilibrium Price | 240 | 1,195 |
Indicative Equilibrium Volume | 1 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Sawit Sumbermas Sarana Tbk (the Company) was established in Jakarta based on the Notarial Deed No. 51 of Enimarya Agoes Suwarko, S.H., dated November 22, 1995.
Read more on SSMS →